Key points are not available for this paper at this time.
Integrated analyses of plasma proteomics and genetic data in prospective studies can help assess the causal relevance of proteins, improve risk prediction, and discover novel protein drug targets for type 2 diabetes (T2D).
Yao et al. (2024) studied this question.